Purchase Order 75N98026P00268
- Not listed
- The National Cancer Institute awarded a one-year firm fixed-price service contract to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on December 10, 2018, for preventative maintenance and support services on a genetic analyzer (Serial #16901-013). The contract, valued at $12,359.96, was executed through a Blanket Purchase Agreement (BPA) call and carries no set-aside designation, reflecting the contractor's competitive positioning in federal scientific procurement....
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $12,989.96 firm fixed-price maintenance agreement by the National Cancer Institute effective April 23, 2019, with an ultimate completion date of April 23, 2020. This contract, which was issued as a Blanket Purchase Agreement (BPA) call with no set-aside designation, covers preventative maintenance and technical support services for scientific laboratory equipment at the performance location in Carlsbad,...
- The National Cancer Institute awarded a $19,905 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on December 2, 2024, with an ultimate completion date of November 1, 2025. This contract is part of the FY26 UDO Initiative and was issued without set-aside designation, reflecting open competitive procurement. Life Technologies Corporation, headquartered in Carlsbad, California, is a leading supplier of scientific instrumentation, reagents, and...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $23,900.04 firm fixed price purchase order to Life Technologies Corporation of Carlsbad, California. The contract is for maintenance services to be performed between December 2023 and December 2024. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division. The award utilizes an existing Government-Wide Acquisition Contract vehicle and...
- Life Technologies Corporation, operating as Thermo Fisher Scientific, received a federal contract award from the National Cancer Institute on March 24, 2021, for a maintenance agreement valued at $19,094.96 with an ultimate completion date of April 28, 2022. This award was issued as a Blanket Purchase Agreement (BPA) call under a firm fixed-price contract structure with no set-aside designation, reflecting the contractor's competitive standing in federal procurement. The work is to be...
- The National Cancer Institute awarded a $18,442.52 firm fixed price maintenance agreement call to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on August 1, 2023, with an ultimate completion date of July 31, 2024. This contract, which was not set aside for any specific category, represents a task order under a larger Blanket Purchase Agreement vehicle and covers preventative maintenance and technical support services for specialized laboratory equipment used in...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $17,482.56 firm fixed price maintenance agreement by the National Cancer Institute on March 17, 2021, with an ultimate completion date of April 15, 2022. This contract was issued as a call under a Blanket Purchase Agreement and was performed at the contractor's facility in Carlsbad, California. The award was not designated as a set-aside contract, reflecting the contractor's competitive standing in federal...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $10,335.04 firm fixed-price maintenance agreement by the National Cancer Institute (NCI) on October 25, 2021, with an ultimate completion date of November 14, 2022. This contract represents a blanket purchase agreement (BPA) call-off and was performed in Bethesda, Maryland. No set-aside designation was utilized for this award. As a prominent manufacturer of scientific instruments, reagents, and...
- This is a $20,209.60 Firm Fixed Price Purchase Order awarded by the National Cancer Institute, an agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for a maintenance agreement with a performance period ending on July 11, 2025. This award does not utilize any set-aside designations. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific and has...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a maintenance agreement contract by the National Cancer Institute on September 22, 2023, with an ultimate completion date of September 21, 2024. This Firm Fixed Price blanket purchase agreement (BPA) call, valued at $18,517.44, requires no set-aside designation and will be performed in Bethesda, Maryland. The contract represents a task order under Life Technologies' existing federal contracting vehicle and...
The National Cancer Institute awarded a $32,249.97 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on April 10, 2026, for maintenance services on a Genetitan 96 Genetic Analyzer. The contract will be performed in Bethesda, Maryland, with an ultimate completion date of April 9, 2027. No set-aside designation was applied to this award, reflecting open competitive procurement. Life Technologies Corporation, headquartered in Carlsbad, California, is a leading supplier of scientific instruments and laboratory equipment to federal agencies, with an extensive portfolio of maintenance and support contracts across the National Institutes of Health, Department of Defense, and other federal entities. This maintenance award supports the National Cancer Institute's laboratory operations and represents a component of Life Technologies' broad federal service portfolio, which includes preventative maintenance, repairs, parts replacement, and technical support for sophisticated genetic analysis equipment. The company maintains multiple indefinite delivery vehicles with federal agencies, including a Department of Veterans Affairs single-award IDV for genetic analyzer maintenance services and an FBI Blanket Purchase Agreement, both established in 2025. These frameworks demonstrate Life Technologies' established position as a critical supplier of specialized laboratory equipment maintenance supporting federal biomedical research missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.2k | 4/8/26 |